NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
30/05/2023
Voltar para busca
Dado oficial do USPTO
B'LANCE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: MistaEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
30/05/2023
Classificação
Registrada
Tipo de marca
Mista
Classes Nice
5
Data de depósito
27/01/2021
Data de registro
30/05/2023
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/05/2023
Última transação
30/05/2023
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
3
Tipo de titular
16
Localização do titular
Berlin, DE
Examinador
DIXON, JENNIFER
Unidade examinadora
M10
Localização atual
PUBLICATION AND ISSUE SECTION
Descrição da marca
The mark consists of the stylized letters "B'LANCE" with an incomplete circle behind the letters "LANC".
Titulares e representantes
Titulares
VIVANT BIOTECHNOLOGY GmbH
Representantes
HUI ZHANG RABIN & BERDO, P.C.
Classificação técnica
Classes Nice
Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Amino acids for medical purposes; Amino acids for veterinary purposes; Dietetic beverages adapted for medical purposes; Dietetic foods adapted for medical purposes; Dietetic substances adapted for medical use; Medicinal drinks; Medicinal infusions for rehydrationnutritionthe delivery of pharmaceutical preparations to prevent and for the treatment of burn-outPTSDanxietydepressioncognitive fatiguechronic Fatigueloss in attentionloss in mental concentrationloss in cognitive perceptionloss in physical and psychological efficiency and performance and similar stress related disordersalcohol and drug intoxications and hangovermuscle fatigue after excessive physical stressserotonin deficiency syndromeneurotransmitter imbalance and long covid; Medicines for human purposes for the prevention and treatment of burn-outPTSDanxietydepressioncognitive fatiguechronic fatigueloss in attentionloss in mental concentrationloss in cognitive perceptionloss in physical and psychological efficiency and performance and similar stress related disordersalcohol and/or drug intoxications and hangovermuscle fatigue after excessive physical stressSerotonin deficiency Syndromeneurotransmitter imbalance and long covid; Pharmaceutical preparations for the prevention and treatment of burn-outPTSDanxietydepressioncognitive fatiguechronic Fatigueloss in attentionloss in mental concentrationloss in cognitive perceptionloss in physical and psychological efficiency and performance and similar stress related disordersalcohol and drug intoxications and hangovermuscle fatigue after excessive physical stressserotonin deficiency syndromeneurotransmitter imbalance and long covid; Pharmaceuticals for the prevention and treatment of burn-outPTSDanxietydepressioncognitive fatiguechronic Fatigueloss in attentionloss in mental concentrationloss in cognitive perceptionloss in physical and psychological efficiency and performance and similar stress related disordersalcohol and drug intoxications and hangovermuscle fatigue after excessive physical stressSerotonin deficiency Syndromeneurotransmitter imbalance and long covid; Pre-filled Syringes sold filled with hyaluronic acidpharmaceuticals and supplementsall containing vitaminsamino acidsproteinscreatineelectrolytestrace elementscoenzymesvital nutrientscarbohydrates; Medicated serums for the prevention and treatment of burn-outPTSDanxietydepressioncognitive fatiguechronic Fatigueloss in attentionloss in mental concentrationloss in cognitive perceptionloss in physical and psychological efficiency and performance and similar stress related disordersalcohol and drug intoxications and hangovermuscle fatigue after excessive physical stressserotonin deficiency Syndromeneurotransmitter imbalance and long covid; Sodium salts for medical purposes; Vitamin preparations; Medicinal infusionsintravenous fluids used for rehydrationnutrition and the delivery of pharmaceutical preparations; Pharmaceuticals and natural remedy preparations for the prevention and treatment of burn-outPTSDanxietydepressioncognitive fatiguechronic Fatigueloss in attentionloss in mental concentrationloss in cognitive perceptionloss in physical and psychological efficiency and performance and similar stress related disordersalcohol and drug intoxications and hangovermuscle fatigue after excessive physical stressSerotonin deficiency Syndromeneurotransmitter imbalance and long covid; Medicines for human purposesintravenous bags sold filled with intravenous fluids used for rehydrationnutritionthe delivery of pharmaceutical preparations for humans; Medicinal infusionsintravenous fluids used for rehydrationnutritionthe delivery of pharmaceutical preparations for humans
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
R.PR
REGISTERED-PRINCIPAL REGISTER
30/05/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
14/03/2023
PUBO
PUBLISHED FOR OPPOSITION
14/03/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
22/02/2023
CNEA
EXAMINERS AMENDMENT MAILED
08/02/2023
OTHE
CASE RETURNED TO EXAMINATION
08/02/2023
IUCN
NOTICE OF ALLOWANCE CANCELLED
08/02/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
01/02/2023
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
01/02/2023
APET
ASSIGNED TO PETITION STAFF
30/01/2023
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
10/01/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
08/11/2022
TMBN
TTAB RELEASE CASE TO TRADEMARKS
29/09/2022
OP.T
OPPOSITION TERMINATED NO. 999999
29/09/2022
OP.D
OPPOSITION DISMISSED NO. 999999
29/09/2022
OP.I
OPPOSITION INSTITUTED NO. 999999
28/06/2022
OPPF
OPPOSITION PAPERS RECEIVED AT TTAB
28/06/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
31/05/2022
PUBO
PUBLISHED FOR OPPOSITION
31/05/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/05/2022
ALIE
ASSIGNED TO LIE
25/04/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
22/04/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/03/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
28/03/2022
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
28/03/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
15/12/2021
GNFR
FINAL REFUSAL E-MAILED
15/12/2021
CNFR
FINAL REFUSAL WRITTEN
15/12/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
16/11/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
15/11/2021
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
15/11/2021
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/09/2021
GNRT
NON-FINAL ACTION E-MAILED
01/09/2021
CNRT
NON-FINAL ACTION WRITTEN
01/09/2021
DOCK
ASSIGNED TO EXAMINER
14/08/2021
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
29/04/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
28/04/2021
NWAP
NEW APPLICATION ENTERED
30/01/2021
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace B'LANCE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.